This commentary discusses recent results on the role of Vav3 in malignancy, in an effort to begin to define the underlying mechanisms and tissue context by which Vav3 proteins, in particular Vav3.1, promote the progression of malignant diseases and further modulate the response to clinically relevant drugs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058338 | PMC |
http://dx.doi.org/10.1634/theoncologist.2017-0683 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!